Literature DB >> 10364344

Thymic tolerance to only one viral protein reduces lymphocytic choriomeningitis virus-induced immunopathology and increases survival in perforin-deficient mice.

M von Herrath1, B Coon, D Homann, T Wolfe, L G Guidotti.   

Abstract

The outcome of viral infections is dependent on the amount of tissue destruction caused either by direct lysis of infected cells and/or by immunopathology resulting from the immune response to the virus. We investigated whether induction of tolerance to only one viral protein could reduce immunopathology caused by nonlytic lymphocytic choriomeningitis virus (LCMV) in perforin-deficient hosts. Earlier studies had shown that LCMV infection results in aplastic anemia and death in most of these mice and that this is associated with bone marrow infiltration by antiviral cytotoxic T lymphocytes (CTL) that secrete inflammatory cytokines. We report here that perforin-deficient mice exhibit severe immunopathology in multiple organs that is characterized by infiltration of anti-LCMV CTL that secrete large amounts of gamma interferon (IFN-gamma) and tumor necrosis factor alpha (TNF-alpha). Importantly, this immunopathology is significantly reduced and long-term survival of LCMV infection is increased in perforin-deficient mice expressing LCMV nucleoprotein (NP) in the thymus (and therefore deleting most of their LCMV-NP CTL) compared to the situation in thymus nonexpressors. This is due to the selective reduction of NP-specific CTL responses and their inflammatory-cytokine (IFN-gamma and TNF-alpha) secretion and to a lack of pathogenetically relevant compensatory responses to other viral proteins. Thus, "selective reduction" of the antiviral immune response to only one viral protein can significantly reduce inflammatory immunopathology and might be a therapeutic possibility for certain nonlytic infections.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10364344      PMCID: PMC112653     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Vaccination and protection from a lethal viral infection: identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope.

Authors:  L S Klavinskis; J L Whitton; E Joly; M B Oldstone
Journal:  Virology       Date:  1990-10       Impact factor: 3.616

2.  Peptide antigen treatment of naive and virus-immune mice: antigen-specific tolerance versus immunopathology.

Authors:  P Aichele; K Brduscha-Riem; S Oehen; B Odermatt; R M Zinkernagel; H Hengartner; H Pircher
Journal:  Immunity       Date:  1997-05       Impact factor: 31.745

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

Review 4.  The virology and immunobiology of lymphocytic choriomeningitis virus infection.

Authors:  M J Buchmeier; R M Welsh; F J Dutko; M B Oldstone
Journal:  Adv Immunol       Date:  1980       Impact factor: 3.543

5.  Immunopathology of adoptive immunization in mice chronically infected with lymphocytic choriomeningitis virus.

Authors:  P E Hoffsten; M B Oldstone; F J Dixon
Journal:  Clin Immunol Immunopathol       Date:  1977-01

6.  Patterns of cytokine gene expression by CD4+ T cells from young and old mice.

Authors:  M V Hobbs; W O Weigle; D J Noonan; B E Torbett; R J McEvilly; R J Koch; G J Cardenas; D N Ernst
Journal:  J Immunol       Date:  1993-04-15       Impact factor: 5.422

7.  Human cytomegalovirus inhibits antigen presentation by a sequential multistep process.

Authors:  K Ahn; A Angulo; P Ghazal; P A Peterson; Y Yang; K Früh
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

8.  Early emergence of ganciclovir-resistant human cytomegalovirus strains in children with primary combined immunodeficiency.

Authors:  D G Wolf; I Yaniv; A Honigman; I Kassis; T Schonfeld; S Ashkenazi
Journal:  J Infect Dis       Date:  1998-08       Impact factor: 5.226

9.  Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes.

Authors:  A Gallimore; A Glithero; A Godkin; A C Tissot; A Plückthun; T Elliott; H Hengartner; R Zinkernagel
Journal:  J Exp Med       Date:  1998-05-04       Impact factor: 14.307

10.  Aplastic anemia rescued by exhaustion of cytokine-secreting CD8+ T cells in persistent infection with lymphocytic choriomeningitis virus.

Authors:  D Binder; M F van den Broek; D Kägi; H Bluethmann; J Fehr; H Hengartner; R M Zinkernagel
Journal:  J Exp Med       Date:  1998-06-01       Impact factor: 14.307

View more
  4 in total

1.  CD8+ T cells specific for immunodominant trans-sialidase epitopes contribute to control of Trypanosoma cruzi infection but are not required for resistance.

Authors:  Charles S Rosenberg; Dianya L Martin; Rick L Tarleton
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

2.  Perforin-deficient CD8+ T cells mediate fatal lymphocytic choriomeningitis despite impaired cytokine production.

Authors:  Pernille Storm; Christina Bartholdy; Maria Rathman Sørensen; Jan Pravsgaard Christensen; Allan Randrup Thomsen
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  T-bet controls autoaggressive CD8 lymphocyte responses in type 1 diabetes.

Authors:  Amy E Juedes; Evelyn Rodrigo; Lisa Togher; Laurie H Glimcher; Matthias G von Herrath
Journal:  J Exp Med       Date:  2004-04-19       Impact factor: 14.307

4.  Hemolysis-associated phosphatidylserine exposure promotes polyclonal plasmablast differentiation.

Authors:  Rahul Vijay; Jenna J Guthmiller; Alexandria J Sturtz; Sequoia Crooks; Jordan T Johnson; Lei Li; Linda Yu-Ling Lan; Rosemary L Pope; Yani Chen; Kai J Rogers; Nirmal Dutta; Jason E Toombs; Mary E Wilson; Patrick C Wilson; Wendy Maury; Rolf A Brekken; Noah S Butler
Journal:  J Exp Med       Date:  2021-06-07       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.